Doctor of Osteopathy Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

David Owens

Vascular & Interventional Radiology Saint Louis, MO Doctor of Osteopathy

NPI 1871952077 CMS profile 4225937

1201 S Grand Blvd, Saint Louis, MO 63104

Open in the dashboard

General payments

$19,801

157 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Owens of Saint Louis, MO is reported in the CMS Open Payments database as having received $19,801 across 157 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,477 55
2024 General $1,779 26
2023 General $6,720 44
2022 General $1,158 17
2021 General $1,667 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Owens
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to David Owens were reported at $8,477. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year David Owens Vascular & Interventional Radiology median Middle half National median
2019 $0 $422 $125–$1,555 $163
2020 $0 $200 $68–$652 $114
2021 $1,667 $280 $99–$866 $132
2022 $1,158 $433 $137–$1,497 $149
2023 $6,720 $506 $152–$2,019 $160
2024 $1,779 $556 $175–$1,930 $164
2025 $8,477 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Penumbra, Inc. $7,532 45 payments
  2. Surefire Medical, Inc. $5,003 19 payments
  3. Medtronic, Inc. $2,264 32 payments
  4. Inari Medical, Inc. $2,033 26 payments
  5. AngioDynamics, Inc. $664 7 payments
  6. Terumo Medical Corporation $507 5 payments
  7. Boston Scientific Corporation $382 5 payments
  8. Philips Electronics North America Corporation $257 2 payments
  9. Surmodics, Inc. $239 2 payments
  10. Cordis US Corp. $204 3 payments
  11. Other $715 11 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $10,729 133 payments
  2. Travel and Lodging $5,516 19 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,194 3 payments
  4. Education $362 2 payments
Products named General payments · program years 2021–2025
  1. Indigo System $6,205 32 payments
  2. TRINAV INFUSION SYSTEM $5,003 19 payments
  3. FLOWTRIEVER CATHETER, S $2,754 34 payments
  4. CT THROMBECTOMY SYSTEM KIT $1,663 20 payments
  5. OSTEOCOOL RF ABLATION SYSTEM $1,060 11 payments
  6. Penumbra System $1,014 11 payments
  7. AURYON LASER SYSTEM 100-120 VAC $600 5 payments
  8. KYPHON EXPRESS II KYPHOPAK TRAY $463 8 payments
  9. CONCERTOTM $366 4 payments
  10. RUBY Coil $314 2 payments
  11. Other $3,214 46 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 87 billing codes

Paid by Medicare

$30,265

Medicare's payments for the services billed

Medicare patients

149

Average age 71

Services billed

367

74 women, 75 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 56%
Diabetes 55%
Arthritis 54%
Ischemic heart disease 50%
Heart failure 44%
Depression 44%
COPD 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

157 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record